Roberto Benelli

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 37

Top Venues

Cancers

Cells

International journal of molecular sciences

Oncoimmunology

IRCCS Ospedale Policlinico San Martino

This page only lists publications with an associated author ORCID identifier.

Affiliation History

IRCCS Ospedale Policlinico San Martino Apr 12 2010

Italy

Dirigente Biologo :: Dipartimento di Staff

Publications

Feliciana Morelli, Serena Matis, Roberto Benelli, Laura Salvini, Maria Raffaella Zocchi, Alessandro Poggi
Antibody-Drug Conjugate Made of Zoledronic Acid and the Anti-CD30 Brentuximab-Vedotin Exert Anti-Lymphoma and Immunostimulating Effects. Cells 13 (10) (2024)
Feliciana Morelli, Serena Matis, Roberto Benelli, Laura Salvini, Maria Raffaella Zocchi, Alessandro Poggi
Antibody-Drug Conjugate Made of Zoledronic Acid and the Anti-CD30 Brentuximab-Vedotin Exert Anti-Lymphoma and Immunostimulating Effects. Cells 13 (10) (2024)
Samuele Tardito, Serena Matis, Maria Raffaella Zocchi, Roberto Benelli, Alessandro Poggi
Epidermal Growth Factor Receptor Targeting in Colorectal Carcinoma: Antibodies and Patient-Derived Organoids as a Smart Model to Study Therapy Resistance. International journal of molecular sciences 25 (13) (2024)
Samuele Tardito, Serena Matis, Maria Raffaella Zocchi, Roberto Benelli, Alessandro Poggi
Epidermal Growth Factor Receptor Targeting in Colorectal Carcinoma: Antibodies and Patient-Derived Organoids as a Smart Model to Study Therapy Resistance. International journal of molecular sciences 25 (13) (2024)
Samuele Tardito, Serena Matis, Maria Raffaella Zocchi, Roberto Benelli, Alessandro Poggi
Epidermal Growth Factor Receptor Targeting in Colorectal Carcinoma: Antibodies and Patient-Derived Organoids as a Smart Model to Study Therapy Resistance. International journal of molecular sciences 25 (13) (2024)
Leila Pisheh, Serena Matis, Martina Taglieri, Linda Di Gregorio, Roberto Benelli, Alessandro Poggi
EGFR-Targeted Antibody-Drug Conjugate to Different Aminobisphosphonates: Direct and Indirect Antitumor Effects on Colorectal Carcinoma Cells. Cancers 16 (7) (2024)
Leila Pisheh, Serena Matis, Martina Taglieri, Linda Di Gregorio, Roberto Benelli, Alessandro Poggi
EGFR-Targeted Antibody-Drug Conjugate to Different Aminobisphosphonates: Direct and Indirect Antitumor Effects on Colorectal Carcinoma Cells. Cancers 16 (7) (2024)
Delfina Costa, Roberta Venè, Simona Coco, Luca Longo, Francesca Tosetti, Stefano Scabini, Luca Mastracci, Federica Grillo, Alessandro Poggi, Roberto Benelli
SB202190 Predicts BRAF-Activating Mutations in Primary Colorectal Cancer Organoids via Erk1-2 Modulation. Cells 12 (4) (2023)
Jordi Leonardo Castrillo Fernandez, Roberto Benelli, Delfina Costa, Alessio Campioli, Sara Tavella, Maria Raffaella Zocchi, Alessandro Poggi
Priming of Colorectal Tumor-Associated Fibroblasts with Zoledronic Acid Conjugated to the Anti-Epidermal Growth Factor Receptor Antibody Cetuximab Elicits Anti-Tumor Vδ2 T Lymphocytes. Cancers 15 (3) (2023)
Delfina Costa, Roberta Venè, Simona Coco, Luca Longo, Francesca Tosetti, Stefano Scabini, Luca Mastracci, Federica Grillo, Alessandro Poggi, Roberto Benelli
SB202190 Predicts BRAF-Activating Mutations in Primary Colorectal Cancer Organoids via Erk1-2 Modulation. Cells 12 (4) (2023)
Samuele Tardito, Serena Matis, Roberto Benelli
The Pleiotropic Effects of Gut Microbiota in Colorectal Cancer Progression: How to Turn Foes into Friends. Cancers 15 (3) (2023)
Samuele Tardito, Serena Matis, Roberto Benelli
The Pleiotropic Effects of Gut Microbiota in Colorectal Cancer Progression: How to Turn Foes into Friends. Cancers 15 (3) (2023)
Serena Matis, Alessandro Poggi, Roberto Benelli
microRNAs in Liquid Biopsy: The Way to a Simple and Rapid Test for Early Colorectal Cancer Diagnosis? Cancers 15 (3) (2023)
Roberto Benelli, Maria Raffaella Zocchi, Alessandro Poggi
Immune Checkpoint Receptor/Ligand Expression and Chemotherapy in Colorectal Cancer. Cancers 15 (3) (2023)
Roberto Benelli, Maria Raffaella Zocchi, Alessandro Poggi
Immune Checkpoint Receptor/Ligand Expression and Chemotherapy in Colorectal Cancer. Cancers 15 (3) (2023)
Delfina Costa, Roberta Venè, Simona Coco, Luca Longo, Francesca Tosetti, Stefano Scabini, Luca Mastracci, Federica Grillo, Alessandro Poggi, Roberto Benelli
SB202190 Predicts BRAF-Activating Mutations in Primary Colorectal Cancer Organoids via Erk1-2 Modulation. Cells 12 (4) (2023)
Roberto Benelli, Maria Raffaella Zocchi, Alessandro Poggi
Evolution of 3D Cultures: Toward Tailored Preclinical Models. Cancers 15 (2) (2023)
Samuele Tardito, Maria Raffaella Zocchi, Roberto Benelli
The Stockholm Syndrome of Cancer: Fibroblasts as a Powerful Shield against Colorectal Cancer Therapy. Cancers 15 (2) (2023)
Roberto Benelli, Maria Raffaella Zocchi, Alessandro Poggi
Evolution of 3D Cultures: Toward Tailored Preclinical Models. Cancers 15 (2) (2023)
Roberto Benelli, Maria Raffaella Zocchi, Alessandro Poggi
Evolution of 3D Cultures: Toward Tailored Preclinical Models. Cancers 15 (2) (2023)
Samuele Tardito, Maria Raffaella Zocchi, Roberto Benelli
The Stockholm Syndrome of Cancer: Fibroblasts as a Powerful Shield against Colorectal Cancer Therapy. Cancers 15 (2) (2023)
Serena Matis, Alessandro Poggi, Roberto Benelli
microRNAs in Liquid Biopsy: The Way to a Simple and Rapid Test for Early Colorectal Cancer Diagnosis? Cancers 15 (3) (2023)
Jordi Leonardo Castrillo Fernandez, Roberto Benelli, Delfina Costa, Alessio Campioli, Sara Tavella, Maria Raffaella Zocchi, Alessandro Poggi
Priming of Colorectal Tumor-Associated Fibroblasts with Zoledronic Acid Conjugated to the Anti-Epidermal Growth Factor Receptor Antibody Cetuximab Elicits Anti-Tumor Vδ2 T Lymphocytes. Cancers 15 (3) (2023)
Samuele Tardito, Maria Raffaella Zocchi, Roberto Benelli
The Stockholm Syndrome of Cancer: Fibroblasts as a Powerful Shield against Colorectal Cancer Therapy. Cancers 15 (2) (2023)
Alessandro Poggi, Serena Matis, Roberto Benelli
The In Vitro Adaptation of Patient-Derived Organoids Suggests Alternative Strategies against CMS1 Colorectal Cancer: When the Microenvironment Does Make the Difference. Cancers 14 (24) (2022)
Alessandro Poggi, Serena Matis, Roberto Benelli
The In Vitro Adaptation of Patient-Derived Organoids Suggests Alternative Strategies against CMS1 Colorectal Cancer: When the Microenvironment Does Make the Difference. Cancers 14 (24) (2022)
Alessandro Poggi, Federico Villa, Jordi Leonardo Castrillo Fernadez, Delfina Costa, Maria Raffaella Zocchi, Roberto Benelli
Three-Dimensional Culture Models to Study Innate Anti-Tumor Immune Response: Advantages and Disadvantages. Cancers 13 (14) (2021)
Roberto Benelli, Delfina Costa, Luca Mastracci, Federica Grillo, Mark Jon Olsen, Paola Barboro, Alessandro Poggi, Nicoletta Ferrari
Erratum: Benelli, R., et al. Aspartate-β-Hydroxylase: A Promising Target to Limit the Local Invasiveness of Colorectal Cancer. Cancers 2020, 12, 971. Cancers 12 (5) (2020)
Roberta Venè, Delfina Costa, Raffaella Augugliaro, Sebastiano Carlone, Stefano Scabini, Gianmaria Casoni Pattacini, Maurizio Boggio, Simonetta Zupo, Federica Grillo, Luca Mastracci, Francesca Pitto, Simona Minghelli, Nicoletta Ferrari, Francesca Tosetti, Emanuele Romairone, Maria C Mingari, Alessandro Poggi, Roberto Benelli
Evaluation of Glycosylated PTGS2 in Colorectal Cancer for NSAIDS-Based Adjuvant Therapy. Cells 9 (3) (2020)
Roberto Benelli, Delfina Costa, Luca Mastracci, Federica Grillo, Mark Jon Olsen, Paola Barboro, Alessandro Poggi, Nicoletta Ferrari
Aspartate-β-Hydroxylase: A Promising Target to Limit the Local Invasiveness of Colorectal Cancer. Cancers 12 (4) (2020)
Simonetta Carluccio, Daniela Martinelli, Maria Elisabetta Federica Palamà, Rui Cruz Pereira, Roberto Benelli, Ana Guijarro, Ranieri Cancedda, Chiara Gentili
Progenitor Cells Activated by Platelet Lysate in Human Articular Cartilage as a Tool for Future Cartilage Engineering and Reparative Strategies. Cells 9 (4) (2020)
Roberto Benelli, Maria Raffaella Zocchi, Alessandro Poggi
Three-Dimensional (3D) Culture Models in Cancer Investigation, Drug Testing and Immune Response Evaluation. International journal of molecular sciences 22 (1) (2020)
Maria Raffaella Zocchi, Francesca Tosetti, Roberto Benelli, Alessandro Poggi
Cancer Nanomedicine Special Issue Review Anticancer Drug Delivery with Nanoparticles: Extracellular Vesicles or Synthetic Nanobeads as Therapeutic Tools for Conventional Treatment or Immunotherapy. Cancers 12 (7) (2020)
Daniele Di Mascolo, Serena Varesano, Roberto Benelli, Hilaria Mollica, Annalisa Salis, Maria Raffaella Zocchi, Paolo Decuzzi, Alessandro Poggi
Nanoformulated Zoledronic Acid Boosts the Vδ2 T Cell Immunotherapeutic Potential in Colorectal Cancer. Cancers 12 (1) (2019)
Abril Saint-Martin, Jacobo Martínez-Ríos, M Cristina Castañeda-Patlán, Miguel Angel Sarabia-Sánchez, Nydia Tejeda-Muñoz, Alberto Chinney-Herrera, Gloria Soldevila, Roberto Benelli, Paula Santoyo-Ramos, Alessandro Poggi, Martha Robles-Flores
Functional Interaction of Hypoxia-Inducible Factor 2-Alpha and Autophagy Mediates Drug Resistance in Colon Cancer Cells. Cancers 11 (6) (2019)
Roberto Benelli, Paola Barboro, Delfina Costa, Simonetta Astigiano, Ottavia Barbieri, Matteo Capaia, Alessandro Poggi, Nicoletta Ferrari
Multifocal Signal Modulation Therapy by Celecoxib: A Strategy for Managing Castration-Resistant Prostate Cancer. International journal of molecular sciences 20 (23) (2019)
Maria Raffaella Zocchi, Delfina Costa, Roberta Venè, Francesca Tosetti, Nicoletta Ferrari, Simona Minghelli, Roberto Benelli, Stefano Scabini, Emanuele Romairone, Silvia Catellani, Aldo Profumo, Alessandro Poggi
Zoledronate can induce colorectal cancer microenvironment expressing BTN3A1 to stimulate effector γδ T cells with antitumor activity. Oncoimmunology 6 (3) (2017)

Roberto Benelli.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Roberto Benelli